Agenda
Times shown are in Central Time.
Agenda subject to change.
Slides approved for release are now available.
Download Presentation
Watch Video
Day 1 - Friday, April 10
Day 2 - Saturday, April 11
Day 1 - Friday, April 10
Interprofessional Session
8:00 – 9:00 AM
Registration, Breakfast & Exhibits
9:00 – 9:15 AM
Welcome, Introductions and Presession ARS
Moderator: Andrew Evens, DO, MBA, MSc
9:15 – 10:35 AM
Mini Symposium on Hodgkin Lymphoma (HL)
Moderator: Andrew Evens, DO, MBA, MSc
9:15 AM
Key Updates in Early-Stage HL
Boyu Hu, MD
9:35 AM
Updated Strategies for Advanced-Stage HL
Sarah Rutherford, MD
9:55 AM
Short- and Long-Term Complications of Immune Checkpoint Inhibitors
Kaitlin Kelly, PharmD, BCOP
10:15 AM
Case Panel Discussion and Audience Q&A
Tara McCabe, APN-BC, AOCNP and Panel
10:35 – 10:55 AM
Break & Exhibits
10:55 – 11:55 AM
Mini Symposium on Long-term Care of the Lymphoma Survivor
Moderator: Sonali Smith, MD, FASCO
10:55 AM
Surveillance of Patients
Allison C. Rosenthal, DO
11:15 AM
Treatment of Complications of Cancer Care: Bone Health, Neuropathy, and Cardiovascular Outcomes
Supreet Kaur, MD
11:35 AM
Panel Discussion and Audience Q&A
Panel
11:55 AM – 1:00 PM
Lunch & Exhibits
General Session
1:00 – 1:05 PM
Welcome, Introductions, and Presession ARS
Moderator: Neha Mehta-Shah, MD, MSCI
1:05 – 2:20 PM
Mini Symposium on Chronic Lymphocytic Leukemia (CLL)
Moderator: Neha Mehta-Shah, MD, MSCI
1:05 PM
What Is the Role of CD19-Targeted Therapies in CLL?
Elijah Darnell, MD
1:25 PM
Richter’s Transformation: Current Considerations and Treatment
Matthew S. Davids, MD, MMSc
1:45 PM
Monotherapy vs Doublets vs Triplets in CLL
Mazyar Shadman, MD, MPH
2:05 PM
Panel Discussion and Audience Q&A
Panel
2:20 – 2:50 PM
Break & Exhibits
2:50 – 3:50 PM
Challenging Clinical Scenarios in HL
- Role of radiation
- For limited stage disease, should we be using novel agents?
- What are the long-term immune-related effects of long-term of immune
checkpoint inhibitors in HL?
- Transplant now vs transplant later
Austin Sim, MD, JD
Sairah Ahmed, MD
Andrew Evens, DO, MBA, MSc
Chicago Area Fellows
3:50 – 5:05 PM
Mini Symposium on Follicular Lymphoma (FL)
Moderator: Timothy Fenske, MD, MS
3:50 PM
Can FL Be Cured?
Nilanjan Ghosh, MD, PhD
4:10 PM
Novel Therapies for FL
Reid W. Merryman, MD
4:30 PM
Prognostication for Follicular Lymphoma in 2026
Carla Casulo, MD
4:50 PM
Panel Discussion and Audience Q&A
Panel
5:05 PM
Day 1 Wrap Up and Summary
Symposium Co-Chairs
5:05 – 6:05 PM
Welcome & Poster Reception with Exhibitors
Day 2 - Saturday, April 11
General Session
7:00 – 8:00 AM
Registration, Breakfast & Exhibits
8:00 – 8:10 AM
Welcome, Introductions, and Presession ARS
Moderator: Andrew Evens, DO, MBA, MSc
8:10 – 8:55 AM
Mini Symposium on Government Policy and Impact on Lymphoma Therapy
Moderator: Andrew Evens, DO, MBA, MSc
8:10 AM
Impact of Government Policy and Federal Funding on Lymphoma Patients
Joanna C. Yang, MD, MPH
8:25 AM
Community Activism and Outreach
Meghan Gutierrez
8:40 AM
Panel Discussion and Audience Q&A
Panel
8:55 – 10:10 AM
Mini Symposium on Diffuse Large B-Cell Lymphoma (DLBCL)
Moderator: Neha Mehta-Shah, MD, MSCI
8:55 AM
Frontline Treatment of DLBCL—Current SoC and Novel Combinations on the Horizon
Joshua Brody, MD
9:15 AM
Understanding DLBCL Classifiers and Their Impact on DLBCL Treatment
Tanaya Shree, MD, PhD
9:35 AM
LymphoMatch: Are We Ready for Precision Medicine in DLBCL?
Brian T. Hill, MD, PhD
9:55 AM
Panel Discussion and Audience Q&A
Panel
10:10 – 10:30 AM
Break & Exhibits
10:30 – 11:50 AM
Duels/Duals in Lymphoma
Moderator: Timothy Fenske, MD, MS
Duals in Lymphoma: What is the Role of NGS and Mutational Profiling in Lymphoma Today?
10:30 AM
Platforms in B-Cell Lymphomas
David Russler-Germain, MD, PhD
10:45 AM
Impact on T-Cell Lymphoma
Teresa Palomero, PhD
Duels in Lymphoma: All Patients with Lymphoma Need to Undergo Next Generation Sequencing (NGS)/Next Generation Profiling
11:00 AM
Yes
Nina Wagner-Johnston, MD
11:15 AM
No
Leo Gordon, MD
11:30 AM
Panel Discussion and Audience Q&A
Panel
11:50 AM – 12:50 PM
Lunch, Exhibits, and Meet the Professor Session
12:50 – 1:45 PM
Mini Symposium on Marginal Zone Lymphoma (MZL)
Moderator: Neha Mehta-Shah, MD, MSCI
12:50 PM
Strategies for Frontline Therapy for MZL
Sonali Smith, MD, FASCO
1:10 PM
MZL Biology and Rational Targets
Juan Pablo Alderuccio, MD
1:30 PM
Panel Discussion and Audience Q&A
Panel
1:45 – 2:45 PM
Keynote Presentation: The Evolution of Treatment for Mantle Cell Lymphoma
Michael Williams, MD, ScM, FACP
2:45 – 3:00 PM
Day 2 Wrap-Up and Summary
Symposium Co-Chairs
3:00 PM